Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
229.9 EUR | -2.75% | +0.47% | +34.62% |
Jul. 15 | Alnylam Pharmaceuticals Insider Sold Shares Worth $1,851,273, According to a Recent SEC Filing | MT |
Jul. 03 | Jerome Powell did it again |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
46.56B | - | |||||
41.67B | ||||||
41.16B | ||||||
28.18B | ||||||
28.1B |